Effects of continuous infusion of endothelin-1 in pregnant sheep.
暂无分享,去创建一个
[1] J. López-Novoa,et al. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation. , 1993, European journal of pharmacology.
[2] G. Remuzzi,et al. Endothelins in the control of cardiovascular and renal function , 1993, The Lancet.
[3] P. Chiu,et al. Attenuation of ischemic acute renal failure by phosphoramidon in rats. , 1993, Pharmacology.
[4] G. Remuzzi,et al. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. , 1993, Kidney international.
[5] H. V. van Geijn,et al. Endothelial vasoactive mediators in preeclampsia. , 1993, American journal of obstetrics and gynecology.
[6] N. Perico,et al. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. , 1993, Kidney international.
[7] K. Badr,et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. , 1992, The New England journal of medicine.
[8] D. Yang,et al. Effect of endothelin-1 on the uterine vasculature of the pregnant and estrogen-treated nonpregnant sheep. , 1992, American journal of obstetrics and gynecology.
[9] J. Whitworth,et al. The kidney in hypertensive pregnancies--victim and villain. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] A. Lerman,et al. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. , 1992, Journal of the American College of Cardiology.
[11] N. Sjöberg,et al. Contractile effect of endothelin in the human uterine artery and autoradiographic localization of its binding sites. , 1992, American journal of obstetrics and gynecology.
[12] H. V. van Geijn,et al. Endothelial function in normal and pre-eclamptic pregnancy: a hypothesis. , 1992, European journal of obstetrics, gynecology, and reproductive biology.
[13] J. Roberts,et al. Pathophysiology of preeclampsia. , 1991, Clinics in perinatology.
[14] B. Sibai,et al. The renin-angiotensin-aldosterone system in preeclampsia. A review. , 1991, Clinics in perinatology.
[15] L. Myatt,et al. Endothelin-1-induced vasoconstriction is not mediated by thromboxane release and action in the human fetal-placental circulation. , 1991 .
[16] M. Sirois,et al. Effects of endothelin‐1 on vascular permeability in the conscious rat: interactions with platelet‐activating factor , 1991, British journal of pharmacology.
[17] M. Mitchell,et al. Maternal plasma level of endothelin is increased in preeclampsia. , 1991, American journal of obstetrics and gynecology.
[18] G. Dekker,et al. Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia. , 1991, European journal of obstetrics, gynecology, and reproductive biology.
[19] D. Gómez-Garre,et al. Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. , 1991, Kidney international.
[20] T. Lüscher,et al. Endothelium-derived relaxing and contracting factors: perspectives in nephrology. , 1991, Kidney international.
[21] J. Roberts,et al. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. , 1990, The Journal of clinical endocrinology and metabolism.
[22] W. Henrich,et al. Endothelial factors in the regulation of renin release. , 1990, Kidney international.
[23] P. Braquet,et al. Involvement of Endothelin in Renal Processes , 1990, Hypertension.
[24] T. Musci,et al. Preeclampsia: an endothelial cell disorder. , 1989, American journal of obstetrics and gynecology.
[25] J. Belda,et al. Outbreak of asthma associated with soybean dust. , 1989, The New England journal of medicine.
[26] J. Roberts,et al. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. , 1988, American journal of obstetrics and gynecology.
[27] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[28] J. Borm,et al. Placental-type plasminogen activator inhibitor in preeclampsia. , 1988, American journal of obstetrics and gynecology.
[29] R. Paul,et al. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. , 1985, The American journal of physiology.
[30] B. Sibai,et al. Biochemical corroboration of endothelial involvement in severe preeclampsia. , 1995, American journal of obstetrics and gynecology.
[31] W. Trick,et al. Therapeutic strategies in the prevention of acute renal failure. , 1994, Seminars in nephrology.
[32] P. Kincaid‐smith,et al. The kidney and hypertension in pregnancy , 1993 .
[33] N. Perico,et al. The possible role of endothelin in the process of progressive renal deterioration in experimental and human glomerulopathies. , 1993, Seminars in nephrology.
[34] K. Takahashi,et al. Endothelin in renal failure. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] M. Redfield,et al. Integrated cardiac, renal, and endocrine actions of endothelin. , 1989, The Journal of clinical investigation.